Journal article
Immunopurification of adenomatous polyposis coli (APC) proteins
KL Elliott, B Catimel, NL Church, JL Coates, AW Burgess, MJ Layton, MC Faux
BMC Research Notes | Published : 2013
Abstract
Background: The adenomatous polyposis coli (APC) tumour suppressor gene encodes a 2843 residue (310 kDa) protein. APC is a multifunctional protein involved in the regulation of β-catenin/Wnt signalling, cytoskeletal dynamics and cell adhesion. APC mutations occur in most colorectal cancers and typically result in truncation of the C-terminal half of the protein. Results: In order to investigate the biophysical properties of APC, we have generated a set of monoclonal antibodies which enable purification of recombinant forms of APC. Here we describe the characterisation of these anti-APC monoclonal antibodies (APC-NT) that specifically recognise endogenous APC both in solution and in fixed cel..
View full abstractGrants
Awarded by National Health and Medical Research Council